Scholarlink

<p>Increasing evidence suggests that C1q/tumor necrosis factor-related proteins (CTRPs), as the adipokine superfamily, are secreted by adipose tissues. They play an important role in diabetic cardiovascular pathology. Diabetic vascular complications pose a significant threat to human health and are the primary cause of disability and mortality in diabetes. Adipose tissue dysfunction, including secretion and dysfunction of adipokines, is closely associated with diabetic vasculopathy. However, the expression levels of CTRPs show heterogeneity in different pathophysiological states, and their potential mechanisms of action have not been elucidated. Therefore, this review aims to summarize and discuss the differences in circulating expression of CTRPs in diabetic patients, as well as their roles and mechanisms in diabetic vasculopathy, to offer new insights and targets for the prevention and treatment of diabetic vasculopathy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The mechanism of C1q/TNF-related proteins (CTRPs) in atherosclerosis associated with type 2 diabetes mellitus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月24日

查看全文
  • Rui Song,
  • Rui Cheng,
  • Gerong Zhang,
  • Jianlu Gao,
  • Yanwei Zhang,
  • Weiting Hu,
  • Wenyu Gong,
  • Fang Wu,
  • Yikun Zhu,
  • Jing Liu

摘要

Increasing evidence suggests that C1q/tumor necrosis factor-related proteins (CTRPs), as the adipokine superfamily, are secreted by adipose tissues. They play an important role in diabetic cardiovascular pathology. Diabetic vascular complications pose a significant threat to human health and are the primary cause of disability and mortality in diabetes. Adipose tissue dysfunction, including secretion and dysfunction of adipokines, is closely associated with diabetic vasculopathy. However, the expression levels of CTRPs show heterogeneity in different pathophysiological states, and their potential mechanisms of action have not been elucidated. Therefore, this review aims to summarize and discuss the differences in circulating expression of CTRPs in diabetic patients, as well as their roles and mechanisms in diabetic vasculopathy, to offer new insights and targets for the prevention and treatment of diabetic vasculopathy.